Scientific article
French

Progrès dans l'immunothérapie des tumeurs cérébrales : difficultés et perspectives

Published in

Revue médicale suisse, vol. 12, no. 516, p. 828-831

Publication date

2016

Abstract

Glioblastomas are highly aggressive tumors. Their prognosis remain poor despite standard therapies combining surgery, radiation and temozolomide based chemotherapy. Among innovating strategies, there is a major interest for immunotherapy. During the past 3 decades, there has been a general scepticism concerning the efficacy of this approach. But the latest achievements, such as immune checkpoint inhibitors in solid tumors, and adoptive cell therapy in hematologic malignancies, have radically changed the face of the field and have already an impact on the daily practice. To which extent these advances have an impact for brain tumors also? This article aims to present the principal clinical applications of the various immune therapies currently under investigation in neurooncology and give an insight on the future perspectives in the field.

Keywords

  • Brain Neoplasms/pathology/therapy
  • Glioblastoma/pathology/therapy
  • Humans
  • Immunotherapy/methods
  • Prognosis

Citation (ISO format)

MIGLIORINI, Denis, DIETRICH, Pierre-Yves. Progrès dans l’immunothérapie des tumeurs cérébrales : difficultés et perspectives. In: Revue médicale suisse, 2016, vol. 12, n° 516, p. 828–831.

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

1660-9379
364views
2downloads

Technical informations

Creation

26/09/2017 17:40:00

First validation

26/09/2017 17:40:00

Update

15/03/2023 02:03:52

Status update

15/03/2023 02:03:52

Last indexation

31/10/2024 07:53:24
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated